Alzheimer Disease Worldwide with over 190 million people by 2040. Study Alzheimer2040.

By: PRLog
PR Log - Mar 09, 2012 - Alzheimer Disease Worldwide with over 190 million people by 2040

Alzheimer disease ( AD ) is a special form of dementia that can start as early as 45 years of age, but mostly around age 65. Alzheimer is one of the 60 known different dementia diseases.

By 2040 it is expected that there are worldwide over 190 million people living with the Alzheimer's disease, in the third stage. Twice as many people do not even know that they are already in a stage of Alzheimer's Disease.

Today it is already a big and fast growing business worldwide and it will have high growth rates to 2040 and a market of over 4560 billion US $. Alzheimer's disease is developing an industry with many branches, services and products and jobs on different levels.

This study (http://www.hkc22.com/alzheimer2040.html) discusses the state of science, applications, companies, research, leading medical institutions, associations, business and industries worldwide and the development to 2040, by years and total. The study took over one year to complete by interviews and using scientific materials, publications and company information. Alzheimer's Disease must not be fate. There are diagnostic methods and prevention, pharmaceuticals and devices, training and education. There are promising scientific research and developments in several countries worldwide. The key is the early diagnosis, but alternative methods like Traditional Chinese Medicine can and will also play an important role in an early stage, similar to vitamins and minerals and more.

This is a new study by Helmut Kaiser Consultancy: Alzheimer2040
http://www.hkc22.com/alzheimer2040.html
For more information please write to email:  hkc22@bluewin.ch
- - -

Research and Consultancy Worldwide is a leading consultancy in life science, pharmaceutical, Medicine, Environmental Protection, Energy and new technologies

Read Full Story - Alzheimer Disease Worldwide with over 190 million people by 2040. Study Alzheimer2040. | More news from this source

Press release distribution by PRLog

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.